Received May 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | Y006122 | — |
No additional AE; HCP calling to report expired administration of VAQTA on 05/22/2025; This spontaneous report was received from a medical assistance referring to a patient, age and gender was not reported. Information regarding the patient's concurrent conditions, medical history, or concomitant medications was not provided. On 22-MAY-2025, the patient was vaccinated with an expiration dose of Hepatitis A Vaccine, Inactivated Suspension for injection (VAQTA), for prophylaxis (dose, route of administration, vaccination scheme frequency, and anatomical location were not provided; valid lot number Y006122, with expiration date on 17-MAY-2025). (Expired product administered). There was not adverse event reported. (No adverse event).